Literature DB >> 6829323

Etiology of mild acute infectious myocarditis. Relation to clinical features.

J Karjalainen, J Heikkilä, M S Nieminen, H Jalanko, M Kleemola, K Lapinleimu, T Sahi.   

Abstract

The etiology of mild myocarditis, diagnosed on the basis of serial ECG changes during an acute infection, was studied in 126 consecutive conscripts. A fourfold rise in the antibody titers in the paired serum samples was required for a positive etiologic diagnosis. An etiologic diagnosis was made probable in 47% of the patients. Adenovirus was incriminated in 19 patients, vaccinia in 12, influenza A in eight, beta-hemolytic Streptococcus in six, mononucleosis in five and Mycoplasma in three. Chlamydia, influenza B and Coxsackie B4 were each found in two patients; parainfluenza, mumps and adult Still's disease were each found in one patient. The incidence of vaccinia myocarditis was 1/10000 smallpox vaccinations. Clear-cut myopericarditis was usually noted during vaccinia, mononucleosis, Mycoplasma, Chlamydia and Coxsackie B4 infections. Adenovirus and influenza A myocarditis was most often subclinical, being mostly detected only because of ECG screening of patients without cardiac symptoms. Frequent recent ventricular extrasystoles were most often triggered by a beta-hemolytic Streptococcus infection. The etiology of infectious myocarditis seems to reflect the overall profile of viruses and other infective agents in the study population at that particular time. Cardiotrophic viruses such as Coxsackie B only rarely cause myocarditis outside epidemics.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6829323     DOI: 10.1111/j.0954-6820.1983.tb03692.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  14 in total

1.  Myopericarditis associated with parainfluenza virus type 3 infection.

Authors:  D Wilks; S M Burns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

2.  Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.

Authors:  Julie Dimier; Audrey Ferrier-Rembert; Karine Pradeau-Aubreton; Matthias Hebben; Danièle Spehner; Anne-Laure Favier; Danielle Gratier; Daniel Garin; Jean-Marc Crance; Robert Drillien
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

3.  A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination.

Authors:  Renata J M Engler; Michael R Nelson; Limone C Collins; Christina Spooner; Brian A Hemann; Barnett T Gibbs; J Edwin Atwood; Robin S Howard; Audrey S Chang; Daniel L Cruser; Daniel G Gates; Marina N Vernalis; Marguerite S Lengkeek; Bruce M McClenathan; Allan S Jaffe; Leslie T Cooper; Steve Black; Christopher Carlson; Christopher Wilson; Robert L Davis
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 4.  What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies.

Authors:  Gary Tse; Jie M Yeo; Yin Wah Chan; Eric T H Lai Lai; Bryan P Yan
Journal:  Front Physiol       Date:  2016-07-21       Impact factor: 4.566

5.  The Prevalence and Findings of Subclinical Influenza-associated Cardiac Abnormalities among Japanese Patients.

Authors:  Takahide Ito; Kanako Akamatsu; Akira Ukimura; Tomohiro Fujisaka; Michishige Ozeki; Yumiko Kanzaki; Nobukazu Ishizaka
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

Review 6.  Special feature for the Olympics: effects of exercise on the immune system: infections and exercise in high-performance athletes.

Authors:  G Friman; L Wesslén
Journal:  Immunol Cell Biol       Date:  2000-10       Impact factor: 5.126

7.  Pre-event smallpox vaccination for healthcare workers revisited--the need for a carefully screened multidisciplinary cadre.

Authors:  John D Malone
Journal:  Int J Infect Dis       Date:  2007-02-15       Impact factor: 3.623

Review 8.  Environmental and infectious conditions in sports.

Authors:  Thomas S Weber
Journal:  Clin Sports Med       Date:  2003-01       Impact factor: 2.182

Review 9.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

Review 10.  Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians.

Authors:  Mathew G Wilson; James H Hull; John Rogers; Noel Pollock; Miranda Dodd; Jemma Haines; Sally Harris; Mike Loosemore; Aneil Malhotra; Guido Pieles; Anand Shah; Lesley Taylor; Aashish Vyas; Fares S Haddad; Sanjay Sharma
Journal:  Br J Sports Med       Date:  2020-09-02       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.